IVZ
46
3
T
50
3
URI
53
-2
V
60
-6
ROK
55
8
MPC
47
3
HRL
39
15
GIS
26
3
AMP
69
-3
VRSN
53
3
DNB
78
6
VRTX
46
2
JNJ
41
2
SCHW
64
2
FMC
31
5
F
43
-8
PVH
52
-3
ZBH
60
-2
UNH
61
6
SIG
43
3
IVZ
46
3
T
50
3
URI
53
-2
V
60
-6
ROK
55
8
MPC
47
3
HRL
39
15
GIS
26
3
AMP
69
-3
VRSN
53
3
DNB
78
6
VRTX
46
2
JNJ
41
2
SCHW
64
2
FMC
31
5
F
43
-8
PVH
52
-3
ZBH
60
-2
UNH
61
6
SIG
43
3
Financhill
Back

BridgeBio Pharma Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51

BBIO
BridgeBio Pharma

Last Price:
23.27
Seasonality Move:
7.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

BridgeBio Pharma Price Quote

$23.27
+0.23 (+1%)
(Updated: November 21, 2024 at 5:55 PM ET)

BridgeBio Pharma Key Stats

Buy
51
BridgeBio Pharma (BBIO) is a Buy
Day range:
$22.05 - $23.16
52-week range:
$21.62 - $44.32
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
18.71
P/B ratio:
0%
Volume:
1.4M
Avg. volume:
1.7M
1-year change:
-21.2%
Market cap:
$4.2B
Revenue:
$9.3M
EPS:
$-2.41

How Much Does BridgeBio Pharma Make?

Is BridgeBio Pharma Growing As A Company?

  • What Is BridgeBio Pharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.33%
  • What Is BridgeBio Pharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

BridgeBio Pharma Stock Price Performance

  • Did BridgeBio Pharma Stock Go Up Last Month?
    BridgeBio Pharma share price went down by -11.45% last month
  • Did BBIO's Share Price Rise Over The Last Year?
    BBIO share price fell by -21.2% over the past 1 year

What Is BridgeBio Pharma 52-Week High & Low?

BridgeBio Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy BridgeBio Pharma?

  • How Much Debt Does BridgeBio Pharma Have?
    Total long term debt quarterly is $1.7B
  • How Much Cash Does BridgeBio Pharma Have?
    Cash and short term investments quarterly total is $266.3M
  • What Is BridgeBio Pharma’s Book Value Per Share?
    Book value per share is -6.51

Is BridgeBio Pharma Cash Flow Positive?

  • What Is BBIO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$450.2M
  • What Is BridgeBio Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $270M
  • What Is BridgeBio Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $64M

BridgeBio Pharma Return On Invested Capital

  • Is Management Doing A Good Job?
    BBIO return on invested capital is -80.46%
  • What Is BridgeBio Pharma Return On Assets?
    ROA measures how assets are converting to revenues and is -62.51%
  • What Is BBIO Return On Equity?
    ROE is a measure of profitability and is 0%

BridgeBio Pharma Earnings Date & Stock Price

BridgeBio Pharma Competitors

  • Who Are BridgeBio Pharma's Competitors?
    Below is a list of companies who compete with BridgeBio Pharma or are related in some way:
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Bristol-Myers Squibb Co (BMY)
    • Pfizer Inc (PFE)
    • PTC Therapeutics Inc (PTCT)
    • Vertex Pharmaceuticals Inc (VRTX)

BridgeBio Pharma Dividend Yield

BridgeBio Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -25.14%
Revenue: -33.22% -19.2%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 47.08
Upside from Last Price: 104.32%

Major Shareholders

  • How many BBIO shares are owned by institutional investors?
    248M BBIO shares are owned by institutional investors
  • How many BBIO shares are owned by insiders?
    7.3M BBIO shares are owned by insiders